Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines

The combined use of zoledronic acid and radiotherapy shows enhanced in vitro cytotoxicity for two human prostate and myeloma cancer cell lines over that expected for a simple additive effect from each treatment alone. A clinical trial is under way to test this combination therapy.